Skip to content

Progesterone Supplementation in Threatened Abortion

Progesterone Supplementation in Threatened Abortion: Is it a Sound Practice?

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03930212
Acronym
Prothreat
Enrollment
190
Registered
2019-04-29
Start date
2018-01-01
Completion date
2018-12-31
Last updated
2023-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Progesterone Resistance, Threatened Abortion

Brief summary

To decide whether progesterone supplementation in threatened abortion is a sound practice.

Detailed description

This study was conducted at Obstetrics and Gynecology Department, Tanta University in the period from January 2018 to December 2018. Patients: Eligible patients (n=190) were randomly allocated into 2 groups; study group who will receive progesterone supplementation (Prog.group) and control group who will receive no treatment (place.group).

Interventions

DRUGProgesterone

received rectal progesterone suppositories 400 mg once daily

DRUGPlacebos

received placebo suppositories rectally once daily.

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* threatened abortion diagnosed by history and ultrasound examination * singleton * viable fetus * gestational age \< 20 weeks * closed normal length cervix.

Exclusion criteria

* short cervix \<2 cm Multiple pregnancy * dead fetus * open cervix ≥ 2cm * history of cervical surgery * refusal to participate.

Design outcomes

Primary

MeasureTime frameDescription
relief of pain3 weeksquestionnaire fulfilled by patient with yes or no questions
completion of pregnancy beyond 20 weeks12 weekspassing the age 20 weeks
Stoppage of bleeding3 weeksCessation of bleeding

Secondary

MeasureTime frameDescription
abortion less than 20 weeks.12 weeksAbortion

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026